摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-溴-4-碘苯胺 | 860435-38-7

中文名称
3-溴-4-碘苯胺
中文别名
——
英文名称
3-bromo-4-iodoaniline
英文别名
——
3-溴-4-碘苯胺化学式
CAS
860435-38-7
化学式
C6H5BrIN
mdl
MFCD09753717
分子量
297.921
InChiKey
HBCBLDVYTZWYLL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    198 °C
  • 沸点:
    323.7±27.0 °C(Predicted)
  • 密度:
    2.292±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2921420090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:5b79aa7df6c9aac20af928a1021a46ae
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Bromo-4-iodoaniline
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromo-4-iodoaniline
CAS number: 860435-38-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H5BrIN
Molecular weight: 297.9

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-溴-4-碘苯胺盐酸四(三苯基膦)钯硫酸 、 cesium fluoride 作用下, 以 四氢呋喃乙醇 为溶剂, 反应 25.33h, 生成
    参考文献:
    名称:
    高荧光固态不对称螺硅杂芴衍生物
    摘要:
    一系列四种不对称芳基取代的 9,9'-spiro-9-silabifluorene (SSF) 衍生物,2,2'-di-tert-butyl-7,7'-diphenyl-9,9'-spiro-9- silabifluorene (PhSSF), 2,2'-di-tert-butyl-7,7'-dipyridin-2-yl-9,9'-spiro-9-silabifluorene (PySSF), 2,2'-di-tert-丁基-7,7'-dibiphenyl-4-yl-9,9'-spiro-9-silabifluorene (BPhSSF), 和 2,2'-di-tert-butyl-7,7'-bis(2',2 ' '-bipyridin-6-yl)-9,9'-spiro-9-silabifluorene (BPySSF) 是通过相应的 2,2'-二硫代联苯与四氯化硅环化制备的。这些新型螺连接
    DOI:
    10.1021/ja042762q
  • 作为产物:
    描述:
    间溴苯胺N,N,N-trimethylbenzenemethanaminium dichloroiodatecalcium carbonate 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以96%的产率得到3-溴-4-碘苯胺
    参考文献:
    名称:
    高荧光固态不对称螺硅杂芴衍生物
    摘要:
    一系列四种不对称芳基取代的 9,9'-spiro-9-silabifluorene (SSF) 衍生物,2,2'-di-tert-butyl-7,7'-diphenyl-9,9'-spiro-9- silabifluorene (PhSSF), 2,2'-di-tert-butyl-7,7'-dipyridin-2-yl-9,9'-spiro-9-silabifluorene (PySSF), 2,2'-di-tert-丁基-7,7'-dibiphenyl-4-yl-9,9'-spiro-9-silabifluorene (BPhSSF), 和 2,2'-di-tert-butyl-7,7'-bis(2',2 ' '-bipyridin-6-yl)-9,9'-spiro-9-silabifluorene (BPySSF) 是通过相应的 2,2'-二硫代联苯与四氯化硅环化制备的。这些新型螺连接
    DOI:
    10.1021/ja042762q
点击查看最新优质反应信息

文献信息

  • Mild and efficient direct aromatic iodination
    作者:Richard Johnsson、Andréas Meijer、Ulf Ellervik
    DOI:10.1016/j.tet.2005.09.051
    日期:2005.12
    transformed into tritium labelled compounds by metal-mediated hydrodehalogenation and also react in a number of important synthetic transformations. We present ICl/In(OTf)3 as a new reagent combination for mild iodination, suitable for acid-sensitive substrates such as carbohydrates.
    芳基化物是重要的合成中间体,可以通过属介导的加氢脱卤作用转化为transformed标记的化合物,并且还可以进行许多重要的合成转化反应。我们提出ICl / In(OTf)3作为用于轻度化的新试剂组合,适用于对酸敏感的底物,例如碳水化合物
  • Rhodium-Catalyzed Synthesis and Optical Properties of Silicon-Bridged Arylpyridines
    作者:Ryo Shintani、Nana Misawa、Ryo Takano、Kyoko Nozaki
    DOI:10.1002/chem.201605000
    日期:2017.2.21
    on the benzene ring, as well as through the protonation or alkylation of the nitrogen atom on the pyridine ring. A catalytic asymmetric synthesis of silicon‐centered axially chiral spirocyclic derivatives has also been achieved with high enantioselectivity by using a newly modified MeO‐MOP (MeO‐MOP=2‐(diphenylphosphino)‐2′‐methoxy‐1,1′‐binaphthyl) derivative as the chiral ligand. These spirocyclic compounds
    通过含的二炔与腈的催化的[2 + 2 + 2]环加成反应,已开发了桥连的4-芳基吡啶的会聚和区域选择性合成方法。已经检查了这些化合物的吸收和发射性质,可以通过改变苯环上的取代基以及通过吡啶环上氮原子的质子化或烷基化来对其进行调节。通过使用新改性的MeO-MOP(MeO-MOP = 2-(二苯基膦基)-2'-甲氧基-1,1'-联萘基),还以高对映选择性实现了以为中心的轴向手性螺环衍生物的催化不对称合成。衍生物作为手性配体。发现这些螺环化合物具有CPL活性(CPL =圆偏振发光),
  • [EN] GUANIDINE COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS DE GUANIDINE ET LEUR UTILISATION
    申请人:IMMUNOMET THERAPEUTICS INC
    公开号:WO2016175357A1
    公开(公告)日:2016-11-03
    The present invention relates to guanidine compounds for inhibiting mitochondrial oxidative phosphorylation (OXPHOS) and use thereof. More specifically, the present invention relates to a pharmaceutical composition for preventing or treating a OXPHOS-related disease, particularly cancer by inhibiting mitochondrial oxidative phosphorylation and reprogramming cellular metabolism.
    本发明涉及用于抑制线粒体氧化磷酸化(OXPHOS)的啉化合物及其使用。更具体地说,本发明涉及一种用于预防或治疗与OXPHOS相关的疾病,特别是通过抑制线粒体氧化磷酸化和重编程细胞代谢的药物组合物。
  • [EN] SUBSTITUTED POLYCYCLIC ANTIBACTERIAL COMPOUNDS<br/>[FR] COMPOSÉS ANTIBACTÉRIENS POLYCYCLIQUES SUBSTITUÉS
    申请人:PTC THERAPEUTICS INC
    公开号:WO2016025932A1
    公开(公告)日:2016-02-18
    The present description relates to substituted polycyclic compounds of Formula (I), Formula (II) or Formula (III): wherein the dashed line represents an optional double bond and Rl, R2, R4, R5, R7, X and Z are as defined herein, and forms and compositions thereof, and also relates to uses of a compound of Formula (I), Formula (II) or Formula (III) or a form thereof and methods for treating or ameliorating Neisseria gonorrhoeae (N. gonorrhoeae) in a subject in need thereof comprising, administering an effective amount of the compound to the subject.
    本描述涉及公式(I)、公式(II)或公式(III)的取代多环化合物:其中虚线代表可选的双键,R1、R2、R4、R5、R7、X和Z的定义如本文所述,以及其形式和组成物,并且涉及使用公式(I)、公式(II)或公式(III)的化合物或其形式以及治疗或缓解需治疗淋病双球菌(N. gonorrhoeae)的患者的方法,包括向患者施用化合物的有效量。
  • [EN] HETEROARYL COMPOUNDS AS INHIBITORS OF RIP2 KINASE, COMPOSITION AND APPLICATION THEREOF<br/>[FR] COMPOSÉS HÉTÉROARYLE UTILISÉS EN TANT QU'INHIBITEURS DE LA KINASE RIP2, COMPOSITION ET APPLICATION DE CEUX-CI
    申请人:ZHANG XIAOHU
    公开号:WO2022192760A1
    公开(公告)日:2022-09-15
    The present disclosure provides heterocycle compounds with RIP2 kinase inhibitory activity, pharmaceutical compositions comprising the same, methods using the same and applications thereof. The present disclosure provides compounds of Formula (I), as inhibitors of RIP2 kinase. These compounds can be used for preventing and/or treating RIP2 kinase-related diseases and/or conditions.
    本公开提供具有RIP2激酶抑制活性的杂环化合物,包括这些化合物的药物组成物,使用这些化合物的方法以及其应用。本公开提供式(I)的化合物,作为RIP2激酶的抑制剂。这些化合物可用于预防和/或治疗与RIP2激酶相关的疾病和/或病况。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫